Preparation method of carrier-free macrolide immunosuppressive drug nanoparticles
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUZHOU UNIV
- Publication Date
- 2019-04-19
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biomaterials and nanotechnology, in particular to a preparation method for self-assembling hydrophobic drugs into carrier-free nanometer drugs. Background technique
[0002] According to the latest global cancer statistics in 2018, there are an estimated 18.19 million new cancer cases and 9.6 million cancer deaths worldwide. In China, about 10,000 people are diagnosed with cancer every day, and 7 people are diagnosed with cancer every minute. Therefore, effectively treating cancer has become an urgent problem in the medical field.
[0003] Immunosuppressants refer to drugs that can suppress the immune response of the body, and can inhibit the proliferation and function of macrophages related to the immune response, such as T cells and B cells, thereby reducing the antibody immune response. Immunosuppressants are currently mainly used for anti-rejection after organ transplantation and autoimmune diseases such as l...